These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38048050)

  • 1. Aneuploidy Landscape in Precursors of Ovarian Cancer.
    Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
    Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.
    Norris EJ; Zhang Q; Jones WD; DeStephanis D; Sutker AP; Livasy CA; Ganapathi RN; Tait DL; Ganapathi MK
    J Pathol; 2019 Jul; 248(3):352-362. PubMed ID: 30883751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions.
    Chien YW; Wang Y; Huang P; Lawson BC; Kolin DL; Chui MH; Vang R; Numan TA; Soong TR; Wang BG; Smith SA; Chen CL; Stone R; Douville C; Wang TL; Shih IM
    Am J Surg Pathol; 2024 Apr; 48(4):475-486. PubMed ID: 38298022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genomic trajectory of ovarian high-grade serous carcinoma can be observed in STIC lesions.
    Cheng Z; Ennis DP; Lu B; Mirza HB; Sokota C; Kaur B; Singh N; Le Saux O; Russo G; Giannone G; Tookman LA; Krell J; Barnes C; McDermott J; McNeish IA
    J Pathol; 2024 Sep; 264(1):42-54. PubMed ID: 38956451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions.
    Wu RC; Wang P; Lin SF; Zhang M; Song Q; Chu T; Wang BG; Kurman RJ; Vang R; Kinzler K; Tomasetti C; Jiao Y; Shih IM; Wang TL
    J Pathol; 2019 May; 248(1):41-50. PubMed ID: 30560554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.
    Visvanathan K; Shaw P; May BJ; Bahadirli-Talbott A; Kaushiva A; Risch H; Narod S; Wang TL; Parkash V; Vang R; Levine DA; Soslow R; Kurman R; Shih IM
    Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy.
    van den Berg CB; Dasgupta S; Ewing-Graham PC; Bart J; Bulten J; Gaarenstroom KN; de Hullu JA; Mom CH; Mourits MJE; Steenbeek MP; van Marion R; van Beekhuizen HJ
    Gynecol Oncol; 2024 Aug; 187():113-119. PubMed ID: 38759517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis.
    Wang Y; Huang P; Wang BG; Murdock T; Cope L; Hsu FC; Wang TL; Shih IM
    Cancer Res; 2022 Dec; 82(24):4528-4541. PubMed ID: 36206311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
    Soong TR; Howitt BE; Miron A; Horowitz NS; Campbell F; Feltmate CM; Muto MG; Berkowitz RS; Nucci MR; Xian W; Crum CP
    J Pathol; 2018 Nov; 246(3):344-351. PubMed ID: 30043522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphologic features of fallopian tubal epithelium in pelvic high-grade serous carcinoma].
    Zhao RJ; Wang YY; Li Z; Wu KY; Kong LF; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):542-547. PubMed ID: 28810294
    [No Abstract]   [Full Text] [Related]  

  • 11. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical Expression Status of p53, CD44v9, and Ki-67 in a Series of Fallopian Tube Lesions of High-grade Serous Carcinoma.
    Sugimoto S; Uchiyama T; Kawahara N; Ohbayashi C; Kobayashi H
    Int J Gynecol Pathol; 2021 Sep; 40(5):419-426. PubMed ID: 34397764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma.
    Novak M; Lester J; Karst AM; Parkash V; Hirsch MS; Crum CP; Karlan BY; Drapkin R
    Gynecol Oncol; 2015 Oct; 139(1):104-11. PubMed ID: 26206555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis.
    Kuhn E; Meeker A; Wang TL; Sehdev AS; Kurman RJ; Shih IeM
    Am J Surg Pathol; 2010 Jun; 34(6):829-36. PubMed ID: 20431479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions.
    Kuhn E; Kurman RJ; Vang R; Sehdev AS; Han G; Soslow R; Wang TL; Shih IeM
    J Pathol; 2012 Feb; 226(3):421-6. PubMed ID: 21990067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma.
    Kuhn E; Kurman RJ; Soslow RA; Han G; Sehdev AS; Morin PJ; Wang TL; Shih IeM
    Am J Surg Pathol; 2012 Dec; 36(12):1826-34. PubMed ID: 22892598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The karyometric signature is altered in fallopian tubes with serous tubal intraepithelial carcinoma.
    Rodriguez GC; Yozwiak M; Nelson OL; Zhang HH; Kim AA; Watkin W; Barton JK; Alberts DS
    Gynecol Oncol; 2024 Jul; 186():110-116. PubMed ID: 38640774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma.
    Mittal N; Srinivasan R; Gupta N; Rajwanshi A; Nijhawan R; Gautam U; Sood S; Dhaliwal L
    Indian J Pathol Microbiol; 2016; 59(4):481-488. PubMed ID: 27721278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 20. Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma.
    Kuhn E; Kurman RJ; Sehdev AS; Shih IeM
    Int J Gynecol Pathol; 2012 Sep; 31(5):416-22. PubMed ID: 22833080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.